Introduction {#sec1_1}
============

Pregnant women and health care providers may not think of non-obstetric causes, especially colorectal cancer for common symptoms of pregnancy like constipation, till it may become advanced \[[@B1]\]. Colorectal cancer can occur in the young during pregnancy even without a family history. Patients may mistake symptoms of colorectal cancer like nausea, abnormal bowel movement, and per rectal bleeding for symptoms of pregnancy, which may lead to a delay in the diagnosis and treatment. These tumors in the young are usually with poor differentiation and higher metastatic potential resulting in poor prognosis \[[@B2]\]. A higher index of suspicion must exist for non-obstetric causes of intestinal obstruction, especially in those with persistent obstruction. A low threshold for investigations is in order to diagnose those with atypical or persistent symptoms. This report stresses the need for a wide range of differentials including malignancy in pregnancy, though it is uncommon.

Case Report {#sec1_2}
===========

A 24-year-old female pregnant with third child (G3P2L2) presented with persistent features of intestinal obstruction, even 2 days after child birth by cesarean section for fetal distress at the end of 36 weeks of gestation. The patient had features of decreased frequency of passing stools, abdominal bloating and tenesmus for the past 2 months of pregnancy which she attributed to the advanced state of her pregnancy. There were occasional episodes of bleeding per rectum for the last month, which the patient thought were due to anal fissure, a condition she had during her previous pregnancy. She had gained about 9 kg of weight since her pregnancy (58--67 kg), but there was a loss of appetite for the past few months, which was attributed by her to the pregnancy. There was no history of melena, jaundice or hematemesis.

There were 2 previous live births and no previous history of abortion. There was no history of familial cancer. Previous antenatal ultrasound done at 3 and 6 months of gestation revealed a well-formed fetus with no abnormalities. She did not present for further visits thereafter till the time of delivery. On examination, the patient was tachycardic and the abdomen was distended. Per rectal examination revealed an ulcer proliferative growth in the lower rectum about 5 cm from the verge almost occluding the lumen.

X-ray showed multiple dilated bowel loops involving the small and large bowel with no evidence of perforation. As a closed-loop obstruction was thought likely, emergency diverting sigmoid loop colostomy was done. Later, CECT of the abdomen (Fig. [1](#F1){ref-type="fig"}) was done which showed circumferential growth involving the middle and distal rectum with right hydroureteronephrosis due to prior extrinsic compression of the right ureter by the gravid uterus. Colonoscopy (Fig. [2](#F2){ref-type="fig"}) showed a lesion of 6 cm from the verge. The scope could not be passed beyond. CEA was 1.9 ng% (*N* \<5 ng%). Colonoscopic biopsy was negative on two successive occasions and the third biopsy was positive for poorly differentiated adenocarcinoma with signet ring features.

The patient was started on FOLFOX chemotherapy, but she developed lung and peritoneal metastasis after 4 months. She refrained from further investigations and died 6 months after colostomy due to disseminated disease.

Discussion {#sec1_3}
==========

Cruveilhier \[[@B3]\] reported the first case of rectal carcinoma in pregnancy in 1842. Colorectal cancer is the seventh most common type of cancer diagnosed in pregnancy, with an estimated incidence of 1 in 13,000 pregnancies \[[@B4]\]. The mean age of diagnosis in a large review was 31 years \[[@B2]\].

The carcinogenesis of colorectal cancer in pregnancy is not fully understood but increased estrogen receptors and progesterone receptors may be involved in the pathogenesis \[[@B5]\]. Cox-2 enzymes are found to be vital to normal pregnancy and high levels are seen in many colorectal tumor cells. This has prompted the inference that Cox-2 inhibitors such as aspirin can alter the course of colon cancer \[[@B6]\].

There are many challenging issues regarding the diagnosis and management of colorectal cancer in pregnancy as it can be masked by the signs and the symptoms of the pregnancy \[[@B1]\]. Abdominal bloating, loss of weight due to malignancy-induced cachexia, and loss of appetite are likely to be masked by pregnancy. Abdominal pain secondary to the partial large-bowel obstruction may be considered as normal uterine cramps. Anorectal bleeding and perianal pain may be misdiagnosed as engorged hemorrhoid and anal fissure, respectively, conditions common in pregnancy \[[@B7]\]. Especially in multiparous women like our patient, occasional rectal bleeding and crampy abdominal pain are more likely to be misdiagnosed as normal course of pregnancy for a few weeks as the trepidation and anxiety for any new symptoms seen in a primigravida is usually not present. Most cases of colorectal cancer are diagnosed late in pregnancy when widespread metastases have occurred \[[@B4]\]. 86% of colorectal tumors found in the rectum during pregnancy occur below the peritoneal reflection in the lower rectum \[[@B8]\]. Hence, this necessitates at least a simple per rectal examination in suspicious cases. Most (60%) are advanced, stage III, and present in the second and third trimester with poor outcomes \[[@B8], [@B9]\].

The role of diagnostic investigations in colorectal cancer like contrast-enhanced computed tomography is limited as it may compromise fetal well-being \[[@B10], [@B11]\]. Ultrasound, though a safe diagnostic modality in pregnancy, has poor accuracy in detecting colon and rectal cancer. Magnetic resonance imaging is relatively safe in pregnancy, but the role of safety of its contrast agents and its availability is a cause for concern \[[@B11], [@B12], [@B13]\].

A gentle flexible rectosigmoidoscopy may be preferred in a suspicion of rectosigmoid cancer in pregnant women, especially in the second trimester. Investigations like completion colonoscopy and endoscopic ultrasound are done in confirmed cases. Carcinoembryonic antigen and liver ultrasound may be needed for those with high pretest probabilities of advanced disease \[[@B2]\].

Treatment of colorectal cancer in pregnancy is challenging and should be started as early as possible keeping in mind the welfare of both mother and child. Generally, in the first 20 weeks of pregnancy, pregnancy may need to be terminated and early cancer treatment should be started as treatment delay can lead to disease progression and maternal mortality. After 20 weeks of pregnancy, the treatment is less well defined. Surgery may be delayed till the fetus is viable and then therapy may be started after consultation \[[@B14]\]. It has been proposed that colon cancer surgery can be done right after an uncomplicated cesarean section \[[@B8]\]. The mode of delivery is generally not affected by cancer, though the placenta should be carefully examined for metastases \[[@B15]\].

Chemotherapy, though safer during the second and third trimester of pregnancy than the first trimester, is associated with an increase in the incidence of intrauterine growth retardation and prematurity as brain development is not yet complete \[[@B16]\].

As most of these rectal cancers are at least stage III necessitating chemoradiation, pelvic radiation and chemotherapy can theoretically compromise the fetus. Most evidence indicates that neoadjuvant chemotherapy in pregnant women with metastatic rectal cancer may spare the fetus though affecting maternal cure rates \[[@B10]\].

Conclusion {#sec1_4}
==========

Challenges of both diagnosis and treatment in colorectal cancer are further compounded by pregnancy. Hence, accurate diagnosis and prompt treatment is the cornerstone in effective management.
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